# MITE in the Treatment of Dyspepsia After Cholecystectomy

> **NCT04786795** · PHASE4 · UNKNOWN · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 990 (estimated)

## Conditions studied

- Patients With Dyspeptic Symptoms After Cholecystectomy

## Interventions

- **DRUG:** Compound Azintamide Enteric-coated Tablets
- **DRUG:** Oryz-aspergillus Enzyme both Pancreatin Tablet and Ursodeoxycholic Acid Tablets

## Key facts

- **NCT ID:** NCT04786795
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-02
- **Target enrollment:** 990 (ESTIMATED)
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04786795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04786795, "MITE in the Treatment of Dyspepsia After Cholecystectomy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04786795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*